{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:10:35Z","timestamp":1784704235038,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Otsuka Pharmaceutical (JP)","award":["Partial Support to this project"],"award-info":[{"award-number":["Partial Support to this project"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0341-0","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T11:38:29Z","timestamp":1473766709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery"],"prefix":"10.1186","volume":"16","author":[{"given":"Tomoko S.","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishio","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akie","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"341_CR1","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/icvts\/ivs208","volume":"15","author":"A Gandhi","year":"2012","unstructured":"Gandhi A, Husain M, Salhiyyah K, Raja SG. Does perioperative furosemide usage reduce the need for renal replacement therapy in cardiac surgery patients? Interact Cardiovasc Thorac Surg. 2012;15:750\u20135.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"341_CR2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s00595-015-1251-y","volume":"45","author":"H Nishi","year":"2015","unstructured":"Nishi H, Toda K, Miyagawa S, Yoshikawa Y, Fukushima S, Kawamura M, et al. Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial. Surg Today. 2015;45:1542\u201351.","journal-title":"Surg Today"},{"key":"341_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10741-011-9245-3","volume":"17","author":"GM Felker","year":"2012","unstructured":"Felker GM. Loop diuretics in heart failure. Heart Fail Rev. 2012;17:305\u201311.","journal-title":"Heart Fail Rev"},{"key":"341_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2796.1995.tb01163.x","volume":"237","author":"C Haller","year":"1995","unstructured":"Haller C, Salbach P, Katus H, K\u00fcbler W. Refractory oedema in congestive heart failure: a contributory role of loop diuretics? J Intern Med. 1995;237:211\u20134.","journal-title":"J Intern Med"},{"key":"341_CR5","doi-asserted-by":"publisher","first-page":"615987","DOI":"10.1155\/2014\/615987","volume":"2014","author":"G Peretto","year":"2014","unstructured":"Peretto G, Durante A, Limite LR, Cianflone D. Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management. Cardiol Res Pract. 2014;2014:615987. doi:\n                    10.1155\/2014\/615987\n                    \n                  .","journal-title":"Cardiol Res Pract"},{"key":"341_CR6","doi-asserted-by":"publisher","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","volume":"290","author":"LC Costello-Boerrigter","year":"2006","unstructured":"Costello-Boerrigter LC, Smith WB, Boerrigter G, Ouyang J, Zimmer CA, Orlandi C, et al. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Am J Physiol Renal Physiol. 2006;290:F273\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl 1","key":"341_CR7","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1007\/s10557-011-6304-x","volume":"25","author":"M Matsuzaki","year":"2011","unstructured":"Matsuzaki M, Hori M, Izumi T, Fukunami M. Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study). Cardiovasc Drugs Ther. 2011;25 Suppl 1:S33\u201345.","journal-title":"Cardiovasc Drugs Ther"},{"key":"341_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/bjs.1800760110","volume":"76","author":"WG Woods","year":"1989","unstructured":"Woods WG, Forsling ML, Le Quesne LP. Plasma arginine vasopressin levels and arterial pressure during open heart surgery. Br J Surg. 1989;76:29\u201332.","journal-title":"Br J Surg"},{"key":"341_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3346\/jkms.1989.4.2.71","volume":"4","author":"WJ Lee","year":"1989","unstructured":"Lee WJ, Choo YE, Song WY, Lee JC, Kim KT, Lee SH. Responses of vasopressin release in patients with cardiopulmonary bypass anesthetized with enflurane and morphine. J Korean Med Sci. 1989;4:71\u20136.","journal-title":"J Korean Med Sci"},{"key":"341_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cardfail.2007.02.005","volume":"13","author":"G Filippatos","year":"2007","unstructured":"Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail. 2007;13:360\u20134.","journal-title":"J Card Fail"},{"key":"341_CR11","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1253\/circj.CJ-12-1390","volume":"77","author":"M Miura","year":"2013","unstructured":"Miura M, Sakata Y, Nochioka K, Takahashi J, Takada T, Miyata S, et al. Prognostic impact of blood urea nitrogen changes during hospitalization in patients with acute heart failure syndrome. Circ J. 2013;77:1221\u20138.","journal-title":"Circ J"},{"key":"341_CR12","first-page":"82","volume":"122","author":"JM Sands","year":"2011","unstructured":"Sands JM, Blount MA, Klein JD. Regulation of renal urea transport by vasopressin. Trans Am Clin Climatol Assoc. 2011;122:82\u201392.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"341_CR13","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure: Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204\u201312.","journal-title":"Crit Care"},{"key":"341_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jccase.2013.07.005","volume":"8","author":"Y Nishizaki","year":"2013","unstructured":"Nishizaki Y, Yamagami S, Sesoko M, Yamashita H, Daida H. Successful treatment of congestive heart failure with concomitant administration of tolvaptan to enhance the effects of furosemide. J Cardiol Cases. 2013;8:151\u20134.","journal-title":"J Cardiol Cases"},{"key":"341_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000047397","volume":"96","author":"DH Ellison","year":"2001","unstructured":"Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology. 2001;96:132\u201343.","journal-title":"Cardiology"},{"key":"341_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1253\/circj.CJ-13-1255","volume":"78","author":"A Shirakabe","year":"2014","unstructured":"Shirakabe A, Hata N, Yamamoto M, Kobayashi N, Shinada T, Tomita K, Tsurumi M, Matsushita M, Okazaki H, Yamamoto Y, Yokoyama S, Asai K, Shimizu W. Immediate administration of tolvaptan prevents the exacerbation of acute kidney injury and improves the mid-term prognosis of patients with severely decompensated acute heart failure. Circ J. 2014;78:911\u201321.","journal-title":"Circ J"},{"key":"341_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.amjmed.2003.11.014","volume":"116","author":"D Aronson","year":"2004","unstructured":"Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med. 2004;116:466\u201373.","journal-title":"Am J Med"},{"key":"341_CR18","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.amjcard.2010.04.024","volume":"106","author":"A Kazory","year":"2010","unstructured":"Kazory A. Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol. 2010;106:694\u2013700.","journal-title":"Am J Cardiol"},{"key":"341_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jacc.2011.01.052","volume":"58","author":"JM Testani","year":"2011","unstructured":"Testani JM, Cappola TP, Brensinger CM, Shannon RP, Kimmel SE. Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol. 2011;58:375\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"341_CR20","unstructured":"Lombardi C, Carubelli V, Rovetta R, Castrini AI, Vizzardi E, Bonadei I, et al. Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure. Panminerva Med. 2015 Jul 8. [Epub ahead of print]"},{"key":"341_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/01.CCM.0000198528.56397.4F","volume":"34","author":"S Jochberger","year":"2006","unstructured":"Jochberger S, Mayr VD, Luckner G, Wenzel V, Ulmer H, Schmid S, et al. Serum vasopressin concentrations in critically ill patients. Crit Care Med. 2006;34:293\u20139.","journal-title":"Crit Care Med"},{"key":"341_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1046\/j.1365-2044.2003.03037.x","volume":"58","author":"E Terazawa","year":"2003","unstructured":"Terazawa E, Dohi S, Akamastsu S, Ohata H, Shimonaka H. Changes in calcitonin gene-related peptide, atrial natriuretic peptide and brain natriuretic peptide in patients undergoing coronary artery bypass grafting. Anaesthesia. 2003;58:223\u201332.","journal-title":"Anaesthesia"},{"key":"341_CR23","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1253\/circj.CJ-14-0244","volume":"78","author":"T Imamura","year":"2014","unstructured":"Imamura T, Kinugawa K, Fujino T, Inaba T, Maki H, Hatano M, Yao A, Komuro I. Increased urine aquaporin-2 relative to plasma arginine vasopressin is a novel marker of response to tolvaptan in patients with decompensated heart failure. Circ J. 2014;78:2240\u20139.","journal-title":"Circ J"},{"key":"341_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2016.02.106","volume":"210","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Nakamura T, Sato E, Node K. Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome. Int J Cardiol. 2016;210:1\u20133.","journal-title":"Int J Cardiol"},{"key":"341_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1471-2369-15-101","volume":"15","author":"JM Jensen","year":"2014","unstructured":"Jensen JM, Mose FH, Kulik AE, Bech JN, Fenton RA, Pedersen EB. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls. BMC Nephrol. 2014;15:101.","journal-title":"BMC Nephrol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0341-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0341-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0341-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T19:32:30Z","timestamp":1487705550000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0341-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0341-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]},"article-number":"181"}}